lixivaptan Articles
FDA advisory negative on Cornerstone's lixivaptan
17 September 2012
Cornerstone acquires Cardiokine
4 January 2012
Showing 1-3 of 3 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
